# Betamethasone Sodium Phosphate and Betamethasone Acetate

NDC: 0517-0799
Generic name: Betamethasone Sodium Phosphate and Betamethasone Acetate
Labeler / Manufacturer: American Regent, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SUSPENSION
Routes: INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR
Marketing started: 20191101

FDA application: ANDA090747

## Active ingredients

- BETAMETHASONE ACETATE: 3 mg/mL
- BETAMETHASONE SODIUM PHOSPHATE: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0517-0799"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0517-0799
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be3e57df-339a-4b7c-9528-d478af8c7855